Gene-diet interactions in brain aging and neurodegenerative disorders
Article Abstract:
While there are many examples of people who live for 100 years or more with little evidence of a decline in brain function, many others are not so fortunate and experience a neurodegenerative disorder, such as Alzheimer disease or Parkinson disease. Although an increasing number of genetic factors that may affect the risk for neurodegenerative disorders are being identified, emerging findings suggest that dietary factors play major roles in determining whether the brain ages successfully or experiences a neurodegenerative disorder. Dietary factors may interact with disease-causing or predisposing genes in molecular cascades that either promote or prevent the degeneration of neurons. Epidemiologic findings suggest that high-calorie diets and folic acid deficiency increase the risk for Alzheimer disease and Parkinson disease; studies of animal models of these disorders have shown that dietary restriction (reduced calorie intake or intermittent fasting) and dietary supplementation with folic acid can reduce neuronal damage and improve behavioral outcome. Animal studies have shown that the beneficial effects of dietary restriction on the brain result in part from increased production of neurotrophic factors and cytoprotective protein chaperones in neurons. By keeping homocysteine levels low, folic acid can protect cerebral vessels and prevent the accumulation of DNA damage in neurons caused by oxidative stress and facilitated by homocysteine. Although additional studies are required in humans, the emerging data suggest that high-calorie diets and elevated homocysteine levels may render the brain vulnerable to age-related neurodegenerative disorders, particularly in persons with a genetic predisposition to such disorders.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease
Article Abstract:
Apolipoprotein(a) seems to increase the risk of Alzheimer's disease in people who have apolipoprotein E epsilon4 but not in people who do not. In a study of 285 patients with Alzheimer disease and 296 healthy volunteers, apolipoprotein (a) caused a six-fold increased risk of Alzheimer's disease at the age of 80 in people with apoE epsilon4. In people who did not have apoE epsilon4, apolipoprotein (a) actually decreased the risk of Alzheimer's disease.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
The effect of Parkinson disease on the nerves of the heart
Article Abstract:
Parkinson's disease can cause loss of nerve function in the heart, according to a study of 29 Parkinson's patients. This was not related to drug treatment and the damage to nerves can be seen on a PET scan after injecting the patient with radioactive dopamine.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Single-gene mutations resulting in reproductive dysfunction in women. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene
- Abstracts: Tolterodine for overactive bladder. Detrol LA and Ditropan XL for overactive bladder. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A randomized controlled trial
- Abstracts: Questions linger about unexplained gene-therapy trial death. Biotechnology industry responds to gene therapy death
- Abstracts: Limitations of listing specific medical interventions in advance directives. Advance Directives for Nursing Home Residents: Achieving Compassionate, Competent, Cost-effective Care
- Abstracts: Type-specific prevalence of genital human papillomaviruses in benign, premalignant, and malignant biopsies in patients from Greece